HN
Hemanth Nandigala
About Hemanth Nandigala
Data last updated:
Hemanth Nandigala has 27 years in corporate governance. Holds Director and Additional Director roles. Currently with 5 companies, including Virchow Laboratories Limited and Virchow Healthcare Private Limited. Formerly with 5 companies, such as Solmed Lifesciences Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2,624 Cr; the largest is Virchow Laboratories Limited at ₹1,480 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Virchow Laboratories Limited U24232TG1982PLC003368 | Director | 29 Jan 1999 | 1982 | ₹1,480 Cr (FY 2025) | Active |
 Virchow Biotech Private Limited U24210TG2001PTC036520 | Managing Director | 04 Apr 2001 | 2001 | ₹758 Cr (FY 2025) | Active |
 Saraca Laboratories Limited U85195TG1988PLC008172 | Director | 04 Nov 2014 | 1988 | ₹310 Cr (FY 2025) | Active |
 Virchow Healthcare Private Limited U24230MH2007PTC176048 | Director | 20 Nov 2007 | 2007 | ₹75.37 Cr (FY 2025) | Active |
| Virchowtech Vaccines & Biologics Private Limited U24304TG2022PTC164664 | Director | 12 Jul 2022 | 2022 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Solmed Lifesciences Private Limited U24239TG2019PTC136292 | Director | 31 Dec 2019 | 2019 | ₹8.89 Cr (FY 2023) | Active |
| Siri Drugs India Private Limited U24232AP2012PTC079367 | Additional Director | 17 Oct 2015 | 2012 | – | Amalgamated |
| Virchow Devices Private Limited U33100TG2019PTC137918 | Director | 25 Dec 2019 | 2019 | ₹2.30 Cr (FY 2023) | Strike Off |
| Virchow Medical Devices Private Limited U33209TG2018PTC126667 | Director | 12 Sep 2018 | 2018 | – | Strike Off |
| Virchow Chemicals Pvt. Ltd U65910TG1988PTC008596 | Director | 01 Apr 2011 | 1988 | ₹120 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemanth Nandigala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemanth Nandigala
Hemanth Nandigala has 27 years in corporate governance. Holds Director and Additional Director roles. Currently with 5 companies, including Virchow Laboratories Limited and Virchow Healthcare Private Limited. Formerly with 5 companies, such as Solmed Lifesciences Private Limited. Engaged in General Business, Healthcare and more. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹2,624 Cr; the largest is Virchow Laboratories Limited at ₹1,480 Cr (FY 2025).
Hemanth Nandigala is associated with 5 companies as Director and Additional Director, including Virchow Laboratories Limited (₹1,480 Cr), Virchow Biotech Private Limited (₹758 Cr), Saraca Laboratories Limited (₹310 Cr).
Hemanth Nandigala has expertise in General Business, Healthcare and other sectors.
Hemanth Nandigala has 27 years in corporate governance.
By reported revenue, the largest current company of Hemanth Nandigala is Virchow Laboratories Limited, with revenue of ₹1,480 Cr (FY 2025).
The 4 current companies of Hemanth Nandigala that report revenue have a combined latest revenue of ₹2,624 Cr.
Hemanth Nandigala currently holds positions at 5 companies: Virchow Laboratories Limited (₹1,480 Cr), Virchow Biotech Private Limited (₹758 Cr), Saraca Laboratories Limited (₹310 Cr), Virchow Healthcare Private Limited (₹75.37 Cr), Virchowtech Vaccines & Biologics Private Limited.